NCT07111052
Lock and Protect: Reducing Adolescent Access to Lethal Means of Suicide
Enrolling by Invitation
NAAges 13–17InterventionalPreventionColumbia UniversityInvestigator-initiated
~50 participants
Updated 2025-12-05 on ClinicalTrials.gov
What's tested:Lock and Protect is a self-administered, web-based decision aid for caregivers of adolescents at risk for suicide.
At a glance
Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Proportion of caregivers who improved home storage of medications and/or firearms
Measured over Baseline (ED visit), 1 month follow-up
Conditions
Where it's being run
1 sites across 1 statesNew York1
Study leadership
- Ashley Blanchard, MD, MS · PRINCIPAL_INVESTIGATOR · Columbia University
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Eligibility criteria
Inclusion
Parents or caregivers of adolescents aged 13-17 years presenting to the ED for suicidal thoughts and/or behaviors or non-suicidal self-injury as defined by presenting complaint or initial provider assessment.
Patients ages 13-17 years-old presenting to the ED for non-suicidal self-injury (NSSI), suicidal thoughts and behaviors
Exclusion
Medically unstable children
Patients with autism, intellectual disability, or active psychosis
Lack of parental and/or youth English and/or Spanish fluency
Caregivers who do not reside in the same home as the patient for at least 2 nights a week
If the caregiver OR patient does not agree to participation both participants will be excluded
What this trial measures
- Proportion of caregivers who improved home storage of medications and/or firearmsBaseline (ED visit), 1 month follow-up
The primary efficacy outcome is change in home access to medications and/or firearms by 1-month post-discharge from the ED, as measured by a REDCap self-administered survey.